Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)

Clinical Trial ID NCT01147211

PubWeight™ 11.49^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01147211

Top papers